Skip to content

Ventilaton, inflammation, perfusion and structure in Neontale Lung patients

Ventilaton, inflammation, perfusion and structure in Neontale Lung patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON29625
Enrollment
18
Registered
2019-06-24
Start date
2019-09-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchopulmonary dyslasia

Interventions

MRI

Sponsors

Erasmus MC- Sophia Children's Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Premature: born before 28 weeks PMA, good enough clinical condition to undergo MRI, parents manage Dutch language, informed consent by parents, at 34-40 weeks PMA: still admitted at the Sophia Children’s Hospital, severe BPD according to NHI criteria or at risk for severe BPD (received 28 days of oxygen therapy) Non- premature: born at a minimum of 37 weeks PMA, good enough clinical condition for MRI, parents manage Dutch language, informed consent by parents

Exclusion criteria

Exclusion criteria: Premature:contraindication for MRI investigation, congenital cardiovascular or pulmonary abnormalities (other than caused by prematurity) Non- premature:contraindication for MRI investigation, obtained mechanical ventilation, congenital cardiovascular or pulmonary abnormalities

Design outcomes

Primary

MeasureTime frame
The technical qualitative assessment of the MRIs

Secondary

MeasureTime frame
The ability of the MRI protocol to detect airway and lung ventilation, inflammation, perfusion and structural changes. Furthermore, the MRIs of prematurely born infants will be compared to the MRIs of non- premature patients without pulmonary disease. And lastly, the technical feasibility of MRI to detect cardiac structures will be assessed.

Contacts

Public ContactBernadette Elders

Erasmus MC- Sophia Children's Hospital

b.elders@erasmusmc.nl0107036661

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)